{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:45:40Z","timestamp":1791888340418,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010129","name":"Maud Kuistilan Muistos\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ygyno.2019.09.010","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T23:22:47Z","timestamp":1570490567000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Viral load of human papillomavirus types 16\/18\/31\/33\/45 as a predictor of cervical intraepithelial neoplasia and cancer by age"],"prefix":"10.1016","volume":"155","author":[{"given":"Tal\u00eda","family":"Malag\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Louvanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnihotram V.","family":"Ramanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Koushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Coutl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2019.09.010_bb0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jnci\/91.6.506","article-title":"Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer","volume":"91","author":"Franco","year":"1999","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ygyno.2019.09.010_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement USPSTF recommendation: screening for cervical CancerUSPSTF recommendation: screening for cervical cancer","volume":"320","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"10.1016\/j.ygyno.2019.09.010_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ypmed.2018.12.021","article-title":"HPV-based cervical screening: rationale, expectations and future perspectives of the new Dutch screening programme","volume":"119","author":"Polman","year":"2019","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.010_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.010_bb0025","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"issue":"6","key":"10.1016\/j.ygyno.2019.09.010_bb0030","first-page":"923","article-title":"Comparison of triage strategies for HPV-positive women: Canadian cervical cancer screening trial results","volume":"26","author":"Isidean","year":"2017","journal-title":"Cancer epidemiology, biomarkers & prevention a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.010_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0969141315606483","article-title":"Implications of semi-quantitative HPV viral load estimation by hybrid capture 2 in colposcopy practice","volume":"23","author":"Basu","year":"2015","journal-title":"J.\u00a0Med. Screen."},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.010_bb0040","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/IGC.0b013e318286a95d","article-title":"Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses","volume":"23","author":"Wang","year":"2013","journal-title":"International Journal of Gynecologic Cancer"},{"issue":"9222","key":"10.1016\/j.ygyno.2019.09.010_bb0045","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(00)02402-8","article-title":"Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study","volume":"355","author":"Ylitalo","year":"2000","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ygyno.2019.09.010_bb0050","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/ijc.22959","article-title":"HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN","volume":"121","author":"Briolat","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.010_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cca.2018.05.016","article-title":"Association between viral loads of different oncogenic human papillomavirus types and the degree of cervical lesions in the progression of cervical Cancer","volume":"483","author":"Wang","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.ygyno.2019.09.010_bb0060","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/ijc.30609","article-title":"Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline\u2014a population-based cohort study","volume":"140","author":"Mittal","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.010_bb0065","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.bjc.6602648","article-title":"Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)","volume":"92","author":"Andersson","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"9328","key":"10.1016\/j.ygyno.2019.09.010_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(02)09463-1","article-title":"Viral load of human papillomavirus and risk of CIN3 or cervical cancer","volume":"360","author":"Lorincz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2019.09.010_bb0075","doi-asserted-by":"crossref","unstructured":"Castle PE, Schiffman M, Wheeler CM, for the AG. Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer. Am. J. Obstet. Gynecol. 2004;191(5):1590\u20137.","DOI":"10.1016\/j.ajog.2004.05.018"},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.010_bb0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ijc.10846","article-title":"Viral load as a predictor of the risk of cervical intraepithelial neoplasia","volume":"103","author":"Schlecht","year":"2003","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"14","key":"10.1016\/j.ygyno.2019.09.010_bb0085","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","article-title":"Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral","volume":"288","author":"Kulasingam","year":"2002","journal-title":"JAMA the journal of the American Medical Association"},{"key":"10.1016\/j.ygyno.2019.09.010_bb0090","author":"Cancer Council Australia Cervical Cancer Screening Guidelines Working Party"},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.010_bb0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cdp.2005.06.007","article-title":"The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia","volume":"29","author":"Koushik","year":"2005","journal-title":"Cancer Detect. Prev."},{"issue":"12","key":"10.1016\/j.ygyno.2019.09.010_bb0100","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/ijc.23459","article-title":"Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia","volume":"122","author":"Ades","year":"2008","journal-title":"International journal of cancer Journal international du cancer"},{"key":"10.1016\/j.ygyno.2019.09.010_bb0105","doi-asserted-by":"crossref","unstructured":"Ferguson R, Ramanakumar AV, Koushik A, Coutl\u00e9e F, Franco E, Roger M, et\u00a0al. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int. J. Cancer. 2012;131(3):E312-E9.","DOI":"10.1002\/ijc.27356"},{"issue":"8","key":"10.1016\/j.ygyno.2019.09.010_bb0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.aids.0000168972.65304.6b","article-title":"High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV","volume":"19","author":"Fontaine","year":"2005","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.010_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jviromet.2003.09.003","article-title":"Real-time PCR assays using internal controls for quantitation of HPV-16 and beta-globin DNA in cervicovaginal lavages","volume":"114","author":"Lefevre","year":"2003","journal-title":"J.\u00a0Virol. Methods"},{"issue":"1","key":"10.1016\/j.ygyno.2019.09.010_bb0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jmv.10539","article-title":"Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages","volume":"72","author":"Lefevre","year":"2004","journal-title":"J.\u00a0Med. Virol."},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2019.09.010_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0166-0934(03)00186-1","article-title":"Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays","volume":"112","author":"Gravitt","year":"2003","journal-title":"J.\u00a0Virol. Methods"},{"issue":"6","key":"10.1016\/j.ygyno.2019.09.010_bb0130","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1128\/JCM.41.6.2763-2767.2003","article-title":"Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated","volume":"41","author":"Weissenborn","year":"2003","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"12","key":"10.1016\/j.ygyno.2019.09.010_bb0135","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/ijc.23006","article-title":"Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix","volume":"121","author":"Khouadri","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.010_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat. Methods Med. Res."},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.010_bb0145","first-page":"715","article-title":"HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections","volume":"8","author":"Manawapat-Klopfer","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.010_bb0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.11222","article-title":"Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study","volume":"106","author":"Dalstein","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2019.09.010_bb0155","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/infdis\/jir049","article-title":"Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study","volume":"203","author":"Xi","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"issue":"11","key":"10.1016\/j.ygyno.2019.09.010_bb0160","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1128\/JCM.01279-15","article-title":"Association of human papillomavirus 31 DNA load with risk of cervical intraepithelial neoplasia grades 2 and 3","volume":"53","author":"Liu","year":"2015","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.010_bb0165","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2007.05.004","article-title":"Viral DNA load, physical status and E2\/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions","volume":"106","author":"Cricca","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2019.09.010_bb0170","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/647993","article-title":"Human papillomavirus (HPV) type 16 and type 18 DNA loads at baseline and persistence of type-specific infection during a 2-year follow-up","volume":"200","author":"Xi","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"issue":"8","key":"10.1016\/j.ygyno.2019.09.010_bb0175","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.28509","article-title":"Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women","volume":"134","author":"Winer","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.010_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcv.2016.07.020","article-title":"Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women","volume":"83","author":"van der Weele","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.ygyno.2019.09.010_bb0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2334-10-326","article-title":"Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women","volume":"10","author":"Ramanakumar","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.010_bb0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.23940","article-title":"High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer","volume":"124","author":"Hesselink","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2019.09.010_bb0195","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/IGC.0b013e318256e5e4","article-title":"Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis","volume":"22","author":"Chen","year":"2012","journal-title":"International journal of gynecological cancer: official journal of the International Gynecological Cancer Society"},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.010_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3747\/co.26.4575","article-title":"Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba","volume":"26","author":"Jalili","year":"2019","journal-title":"Current oncology (Toronto, Ont)."},{"issue":"1","key":"10.1016\/j.ygyno.2019.09.010_bb0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/jms.2012.012011","article-title":"Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec","volume":"19","author":"Cerigo","year":"2012","journal-title":"J.\u00a0Med. Screen."},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.010_bb0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/infdis\/jiy507","article-title":"Role of human papillomavirus DNA load in predicting the long-term risk of cervical cancer: a 15-year prospective cohort study in China","volume":"219","author":"Zhao","year":"2018","journal-title":"J.\u00a0Infect. Dis."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:45:14Z","timestamp":1758771914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819315306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0090825819315306"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral load of human papillomavirus types 16\/18\/31\/33\/45 as a predictor of cervical intraepithelial neoplasia and cancer by age","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}